Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

K-ras mutation in tamoxifen-related endometrial polyps.

Cancer - 1 Nov 2003

Hachisuga Toru, Miyakawa Takashi, Tsujioka Hiroshi, Horiuchi Shinji, Emoto Makoto, Kawarabayashi Tatsuhiko

Abstract excerpt

BACKGROUND: K-ras mutation is thought to occur at an early stage of neoplastic progression in the endometrium. The authors investigated mutations in codon 12 of K-ras in tamoxifen (TAM)-related endometrial polyps. METHODS: DNA was extracted from 11 frozen endometrial polyps from TAM-treated patients with breast carcinoma. Mutations were detected using the mutant allele-specific amplification method. The results...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Hormonal
Share to Endometrial Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, ras

Share to Polyps

Share to Precancerous Conditions

Share to Receptors, Estrogen

Share to Receptors, Progesterone

Share to Tamoxifen

Source

Identifiers

PMID: 14584071
DOI: 10.1002/cncr.11728

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

K-ras mutation in tamoxifen-related endometrial polyps.PMID 14584071Read ↗

Endometrial K-ras mutations in postmenopausal breast cancer patients treated with adjuvant tamoxifen or toremifene.Semantic proximity Read ↗

Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma.Semantic proximity Read ↗

K-ras activation in premalignant and malignant epithelial lesions of the human uterus.Semantic proximity Read ↗

Monitoring of endometrial K-ras mutation in tamoxifen-treated patients with breast cancer.Semantic proximity Read ↗

Mutations of the Ki-ras oncogene in carcinoma of the endometrium.Semantic proximity Read ↗

Apoptosis as a possible candidate mechanism for removal of tamoxifen-related endometrial cells with KRAS mutations.Semantic proximity Read ↗

Endometrial carcinomas with significant mucinous differentiation associated with higher frequency of k-ras mutations: a morphologic and molecular correlation study.Semantic proximity Read ↗

K-ras mutation in the endometrium of tamoxifen-treated breast cancer patients, with a comparison of tamoxifen and toremifene.Semantic proximity Read ↗

Alteration of the p53 tumor suppressor gene and activation of c-K-ras-2 protooncogene in endometrial adenocarcinoma from Colorado.Semantic proximity Read ↗

Alterations of the K-ras and p53 genes in Tamoxifen-associated endometrial carcinoma.Semantic proximity Read ↗

Analysis of oncogene alterations in human endometrial carcinoma: prevalence of ras mutations.Semantic proximity Read ↗

Molecular basis of endometrial cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.